Home / Japan / Takashima & Co.,Ltd.
Takashima & Co.,Ltd.
Short position disclosed on September 2, 2026.
0.52% of the capital sold short
1 disclosing funds
1 disclosures on record
Evolution of the disclosed total
0%0.2%0.4%0.6%
Sep 3Sep 4
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| UBS AG | 0.52% | unchanged | September 2, 2026 |
Get the moves on Takashima & Co.,Ltd. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 2, 2026 | UBS AG | 0.52% | still open |
Download 1 filing as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- KLab Inc. 17.64% of the capital sold short
- Towa Corporation 14.20% of the capital sold short
- ReYuu Japan Inc. 12.56% of the capital sold short
- 3-D Matrix,Ltd. 11.82% of the capital sold short
- Sanrio Company,Ltd. 10.58% of the capital sold short
- SHIFT Inc. 10.19% of the capital sold short
- QD Laser,Inc. 10.05% of the capital sold short
- AIMECHATEC,Ltd. 9.66% of the capital sold short
- V Technology Co.,Ltd. 9.25% of the capital sold short
- Tri Chemical Laboratories Inc. 9.24% of the capital sold short
- Oncolys BioPharma Inc. 9.12% of the capital sold short
- Nissan Motor Co.,ltd. 8.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Takashima & Co.,Ltd., source JPX, data as at September 2, 2026, https://www.quivad.com/action/takashima-co-ltd